Fig. 3

Analysis of changes in ocular surface inflammatory factors VEGF, IL-1β, PGE2, and TNF-α in each group after 28 days of drug treatment.
Analysis of changes in ocular surface inflammatory factors VEGF, IL-1β, PGE2, and TNF-α in each group after 28 days of drug treatment.